Viral vector production system

1. A viral vector production system comprising a nucleic acid sequence encoding packaging components and a vector genome comprising an RNA-binding protein (RBP) binding site operably linked to a nucleotide of interest (NOI), wherein the RBP is heterologous to the NOI, wherein the RBP is tryptophan RNA-binding attenuation protein (TRAP), and wherein the RBP binding site is capable of interacting with an RBP such that translation of the NOI is repressed in a viral vector production cell.

2. The viral vector production system of claim 1 , wherein the viral vector is a retroviral vector and wherein the viral vector production system comprises nucleic acid sequences encoding Gag and Pol proteins, the RNA-binding protein, and Env protein.

3. The viral vector production system of claim 2 , wherein the viral vector is a lentiviral vector.

4. A viral vector production cell comprising the viral vector production system of claim 1 .

5. The viral vector production cell of claim 4 , wherein the cell is transiently transfected with a nucleic acid sequence encoding an RBP capable of interacting with the RBP binding site.

6. The viral vector production cell of claim 4 , wherein the cell stably expresses an RBP capable of interacting with the RBP binding site.

7. A process for producing a viral vector, the process comprising introducing the viral vector production system of claim 1 into a viral vector production cell and culturing the production cell under conditions suitable for the production of the viral vector.

8. A method of increasing viral vector titers in a eukaryotic vector production cell, the method comprising introducing into the eukaryotic vector production cell the viral vector production system of claim 1 and a nucleic acid sequence encoding an RNA binding protein (RBP), wherein the RBP binds to the RBP binding site and represses translation of the NOI, thereby increasing viral vector titers relative to a viral vector having no RBP binding site.